{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:13:06Z","timestamp":1792804386226,"version":"4.5.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.nano.2008.07.004","type":"journal-article","created":{"date-parts":[[2008,9,28]],"date-time":"2008-09-28T08:19:33Z","timestamp":1222589973000},"page":"46-54","source":"Crossref","is-referenced-by-count":52,"title":["In vivo studies of polyacrylate nanoparticle emulsions for topical and systemic applications"],"prefix":"10.1016","volume":"5","author":[{"given":"Kerriann","family":"Greenhalgh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Turos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nano.2008.07.004_bib1","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1038\/431892a","article-title":"Antibiotics: A shot in the arm","volume":"431","author":"Zafeiris","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.nano.2008.07.004_bib2","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/01.md.0000091184.93122.09","article-title":"Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study","volume":"82","author":"Chang","year":"2003","journal-title":"Medicine"},{"key":"10.1016\/j.nano.2008.07.004_bib3","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1128\/AAC.49.8.3435-3441.2005","article-title":"Establishment of a superficial skin infection model in mice by using Staphylococcus aureus and Streptococcus pyogenes","volume":"49","author":"Kugelberg","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.nano.2008.07.004_bib4","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1146\/annurev.micro.55.1.77","article-title":"Toxic shock syndrome and bacterial superantigens: an update","volume":"55","author":"McCormick","year":"2001","journal-title":"Annu Rev Microbiol"},{"key":"10.1016\/j.nano.2008.07.004_bib5","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0924-8579(98)00081-8","article-title":"Improved efficacy with non-simultaneous administration of netilmicin and minocycline against methicillin\u2013resistant Staphylococcus aureus in in vitro and in vivo models","volume":"11","author":"Goto","year":"1999","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.nano.2008.07.004_bib6","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S1473-3099(05)01283-1","article-title":"Lack of development of new antimicrobial drugs: a potential serious threat to public health","volume":"5","author":"Norrby","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.nano.2008.07.004_bib7","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.bmcl.2006.09.098","article-title":"Antibiotic-conjugated polyacrylate nanoparticles: new opportunities for development of anti-MRSA agents","volume":"17","author":"Turos","year":"2007","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.nano.2008.07.004_bib8","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nrmicro727","article-title":"Where will new antibiotics come from?","volume":"1","author":"Walsh","year":"2003","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.nano.2008.07.004_bib9","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1126\/science.284.5418.1318","article-title":"Bacterial biofilms: a common cause of persistent infections","volume":"284","author":"Costerton","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.nano.2008.07.004_bib10","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.coph.2005.06.002","article-title":"\u03b2-lactams against methicillin-resistant Staphylococcus aureus","volume":"5","author":"Guignard","year":"2005","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.nano.2008.07.004_bib11","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1177\/106002809603000417","article-title":"Amphotericin B formulated in a liquid emulsion","volume":"30","author":"Cleary","year":"1996","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.nano.2008.07.004_bib12","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1093\/infdis\/158.5.1065","article-title":"An emulsion formulation of amphotericin B improves the therapeutic index when treating systemic murine candidiasis","volume":"158","author":"Kirsh","year":"1988","journal-title":"J Infect Dis"},{"key":"10.1016\/j.nano.2008.07.004_bib13","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/j.2042-7158.1991.tb03529.x","article-title":"Toxicity of amphotericin B emulsion to cultured canine kidney cell monolayers","volume":"43","author":"Lamb","year":"1991","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.nano.2008.07.004_bib14","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/jac\/36.1.119","article-title":"Structure and toxicity of amphotericin B\/triglyceride emulsion formulations","volume":"36","author":"Lance","year":"1995","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.nano.2008.07.004_bib15","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/jac\/32.1.123","article-title":"In-vitro and in-vivo studies of the decrease of amphotericin B toxicity upon association with a triglyceride-rich emulsion","volume":"32","author":"Souza","year":"1993","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.nano.2008.07.004_bib16","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1097\/00003246-199608000-00007","article-title":"Administration of amphotericin B in lipid emulsion decreases nephrotoxicity: results of a prospective, randomized, controlled study in critically ill patients","volume":"24","author":"Sorkine","year":"1996","journal-title":"Crit Care Med"},{"key":"10.1016\/j.nano.2008.07.004_bib17","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1093\/jac\/31.5.806","article-title":"Toxicity of amphotericin B emulsion formulations","volume":"31","author":"Washington","year":"1993","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.nano.2008.07.004_bib18","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1128\/IAI.20.3.856-860.1978","article-title":"Toxicity of emulsified trehalose-6,6\u2032-dimycolate (cord factor) in mice depends on size distribution of mineral oil droplets","volume":"20","author":"Yarkoni","year":"1978","journal-title":"Infect Immun"},{"key":"10.1016\/j.nano.2008.07.004_bib19","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1080\/02652040400008515","article-title":"Polycarboxylic acid nanoparticles for ophthalmic drug delivery: an ex vivo evaluation with human cornea","volume":"21","author":"De","year":"2004","journal-title":"J Microencapsul"},{"key":"10.1016\/j.nano.2008.07.004_bib20","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1021\/nl034396z","article-title":"Presenting vancomycin on nanoparticles to enhance antimicrobial activity","volume":"3","author":"Gu","year":"2003","journal-title":"Nano Lett"},{"key":"10.1016\/j.nano.2008.07.004_bib21","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1177\/0021998306067321","article-title":"Polymer-matrix nanocomposites, processing, manufacturing, and application: an overview","volume":"40","author":"Hussain","year":"2006","journal-title":"J Compos Mater"},{"key":"10.1016\/j.nano.2008.07.004_bib22","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1088\/0957-4484\/16\/10\/059","article-title":"The bactericidal effect of silver nanoparticles","volume":"16","author":"Morones","year":"2005","journal-title":"Nanotechnology"},{"key":"10.1016\/j.nano.2008.07.004_bib23","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1126\/science.1114397","article-title":"Toxic potential of materials at the nanolevel","volume":"311","author":"Ne","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.nano.2008.07.004_bib24","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1021\/la0358567","article-title":"Ciprofloxacin-protected gold nanoparticles","volume":"20","author":"Renjis","year":"2004","journal-title":"Langmuir"},{"key":"10.1016\/j.nano.2008.07.004_bib25","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.lfs.2006.09.040","article-title":"Chitosan nanoparticle as gene therapy vector via gastrointestinal mucosa administration: Results of an in vitro and in vivo study","volume":"80","author":"Zheng","year":"2007","journal-title":"Life Sci"},{"key":"10.1016\/j.nano.2008.07.004_bib26","doi-asserted-by":"crossref","first-page":"4647","DOI":"10.1016\/S0032-3861(00)00854-5","article-title":"Viscoelastic and mechanical properties of poly(butyl acrylate-styrene) copolymers","volume":"42","author":"Cerrada","year":"2001","journal-title":"Polymer"},{"key":"10.1016\/j.nano.2008.07.004_bib27","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/jat.2550090310","article-title":"Characterization of toxicity involving hemorrhage and cardiovascular failure, caused by parenteral administration of a soluble polyacrylate in the rat","volume":"9","author":"Hicks","year":"1989","journal-title":"J Appl Toxicol"},{"key":"10.1016\/j.nano.2008.07.004_bib28","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S1461-5347(98)00100-X","article-title":"Macromolecules as safe penetration enhancers for hydrophilic drugs-a fiction?","volume":"1","author":"Junginger","year":"1998","journal-title":"Pharm Sci Technol Today"},{"key":"10.1016\/j.nano.2008.07.004_bib29","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/jat.2550150115","article-title":"Long-term effects of a cross-linked polyacrylate superabsorbent in the hamster","volume":"15","author":"McGrath","year":"1994","journal-title":"J Appl Toxicol"},{"key":"10.1016\/j.nano.2008.07.004_bib30","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3109\/10915819309140631","article-title":"Teratology study of a cross-linked polyacrylate superabsorbent polymer","volume":"12","author":"Mcgrath","year":"1993","journal-title":"J Am Coll Toxicol"},{"key":"10.1016\/j.nano.2008.07.004_bib31","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3109\/01480548908999147","article-title":"Studies of the developmental toxicity of polycarboxylate dispersing agents","volume":"12","author":"Nolen","year":"1989","journal-title":"Drug Chem Toxicol"},{"key":"10.1016\/j.nano.2008.07.004_bib32","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/jbm.820080107","article-title":"Studies of the stability and toxicity of zinc polyacrylate (polycarboxylate) cements (PAZ)","volume":"8","author":"Peters","year":"1974","journal-title":"J Biomed Mater Res"},{"key":"10.1016\/j.nano.2008.07.004_bib33","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/00003086-197210000-00034","article-title":"Biological response to zinc polyacrylate cement","volume":"88","author":"Peters","year":"1972","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.nano.2008.07.004_bib34","article-title":"Thermosetting polyacrylate powder coating compositions","author":"Reich","year":"1996","journal-title":"European Patent Application"},{"key":"10.1016\/j.nano.2008.07.004_bib35","first-page":"34","article-title":"Bactericidal and antitoxic effects of synthetic polymers (review)","volume":"9","author":"Tarasov","year":"1967","journal-title":"Voen Med Zh"},{"key":"10.1016\/j.nano.2008.07.004_bib36","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0753-3322(99)80088-2","article-title":"Prevention of topical and ocular oxidative stress by positively charged submicron emulsion","volume":"53","author":"Benita","year":"1999","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.nano.2008.07.004_bib37","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/00000441-199207000-00012","article-title":"Propofol: a review of the pharmacology and applications of an intravenous anesthetic agent","volume":"304","author":"Deegan","year":"1992","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.nano.2008.07.004_bib38","first-page":"472","article-title":"Reducing pain during propofol injection: the role of the solvent","volume":"82","author":"Doenicke","year":"1996","journal-title":"Anesth Analg"},{"key":"10.1016\/j.nano.2008.07.004_bib39","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0378-5173(89)90329-3","article-title":"Design and characterization of submicronized o\/w emulsion of diazepam for parenteral use","volume":"54","author":"Levy","year":"1989","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2008.07.004_bib40","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0169-409X(95)00114-M","article-title":"Lipid microspheres (lipid emulsions) as a drug carrier\u2014an overview","volume":"20","author":"Mizushima","year":"1996","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2008.07.004_bib41","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/bja\/55.1.41","article-title":"Fat emulsion as a vehicle for diazepam: a study of 9,492 patients","volume":"55","author":"van Dardel","year":"1981","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.nano.2008.07.004_bib42","doi-asserted-by":"crossref","first-page":"3468","DOI":"10.1016\/j.bmcl.2007.03.077","article-title":"Penicillin-bound polyacrylate nanoparticles: restoring the activity of \u03b2-lactam antibiotics against MRSA","volume":"17","author":"Turos","year":"2007","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.nano.2008.07.004_bib43","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1128\/AAC.49.6.2260-2266.2005","article-title":"Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections","volume":"49","author":"Weigelt","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.nano.2008.07.004_bib44","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1128\/AAC.47.8.2507-2512.2003","article-title":"In vivo antibacterial activity of S-3578, a new broad-spectrum cephalosporin: methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa experimental infection models","volume":"47","author":"Tsuji","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.nano.2008.07.004_bib45","first-page":"1","article-title":"Methods for purifying and detoxifying sodium dodecyl sulfate\u2013stabilized polyacrylate nanoparticles","volume":"4","author":"Garay-Jimenez","year":"2008","journal-title":"Nanomedicine"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963408001196?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963408001196?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T17:30:04Z","timestamp":1588959004000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963408001196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S1549963408001196"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2008.07.004","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}